CATHERINE J MACKEY

CIK 1645330 · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

8

Total Filings

33

Lifetime Open-Market Net

-$37.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VYGR Director $3.50 $0 5 2026-06-11
IDYA Director $28.98 $0 4 2025-06-26
Avid Bioservices, Inc. (CDMO) Delisted Director 43,379 $12.49 $541.8K $0 4 2024-12-17
Trillium Therapeutics Inc. (TRIL) Delisted Director $19.86 $0 1 2021-07-02
GW PHARMACEUTICALS PLC (GWPH) Delisted Director 10,536 $218.96 $2.31M -$37.2K 8 2021-03-02
Avid Bioservices, Inc. (CDMOP) Delisted Director $25.06 $0 3 2020-12-16
Poseida Therapeutics, Inc. (PSTX) Delisted Director $9.50 $0 1 2020-07-13
SEQUENOM INC (SQNM) Delisted Director 0 $0 4 2016-09-07

Recent Filings · Page 4 of 4

33 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-06-16 SEQUENOM INC (SQNM) Delisted Grant (A) $0 EDGAR
2016-01-06 SEQUENOM INC (SQNM) Delisted Grant (A) +21,114 $0 EDGAR
2015-06-18 SEQUENOM INC (SQNM) Delisted Grant (A) $0 EDGAR
Showing 3133 of 33
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.